Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) has a beta value of 0.63 and has seen 2.52 million shares traded in the recent trading session. The company, currently valued at $19.02B, closed the recent trade at $16.58 per share which meant it gained $0.18 on the day or 1.12% during that session. The TEVA stock price is -37.52% off its 52-week high price of $22.80 and 24.79% above the 52-week low of $12.47. If we look at the company’s 10-day average daily trading volume, we find that it stood at 9.31 million shares traded. The 3-month trading volume is 11.47 million shares.
The consensus among analysts is that Teva- Pharmaceutical Industries Ltd. ADR (TEVA) is Buy stock at the moment, with a recommendation rating of 1.40. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 8 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) trade information
Sporting 1.12% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TEVA stock price touched $16.58 or saw a rise of 2.87%. Year-to-date, Teva- Pharmaceutical Industries Ltd. ADR shares have moved -2.34%, while the 5-day performance has seen it change -1.59%. Over the past 30 days, the shares of Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) have changed -4.26%. Short interest in the company has seen 40.0 million shares shorted with days to cover at 3.61.
Wall Street analysts have a consensus price target for the stock at $22, which means that the shares’ value could jump 24.64% from the levels at last check today.. The projected low price target is $10.0 while the price target rests at a high of $28.0. In that case, then, we find that the latest price level in today’s session is -68.88% off the targeted high while a plunge would see the stock lose 39.69% from the levels at last check today..
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) estimates and forecasts
The company’s shares have lost -22.83% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.62% over the past 5 years. Earnings growth for 2025 is a modest 1.95% while over the next 5 years, the company’s earnings are expected to increase by 7.74%.
TEVA Dividends
Teva- Pharmaceutical Industries Ltd. ADR is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA)’s Major holders
Insiders own 0.00% of the company shares, while shares held by institutions stand at 64.52% with a share float percentage of 64.52%. Investors are also buoyed by the number of investors in a company, with Teva- Pharmaceutical Industries Ltd. ADR having a total of 750.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 42.99 million shares worth more than $698.55 million. As of 2024-06-30, BLACKROCK INC. held 3.7942% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 41.98 million shares as of 2024-06-30. The firm’s total holdings are worth over $682.15 million and represent 3.7051% of shares outstanding.